These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 950588)

  • 1. Comparative bioavailability: eight commercial prednisone tablets.
    Sullivan TJ; Hallmark MR; Sakmar E; Weidler DJ; Earhart RH; Wagner JG
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):157-72. PubMed ID: 950588
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo availability of commercial prednisone tablets.
    Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
    J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative bioavailability of prednisone and prednisone acetate tablets].
    Jia YR; Zhou BY; Zhou WB; Lei YD; Zhou Q
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):259-61. PubMed ID: 3837381
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of food on the bioavailability of prednisone.
    Tembo AV; Sakmar E; Hallmark MR; Weidler DJ; Wagner JG
    J Clin Pharmacol; 1976; 16(11-12):620-4. PubMed ID: 791973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of prednisone in humans.
    Disanto AR; Desante KA
    J Pharm Sci; 1975 Jan; 64(1):109-12. PubMed ID: 1133681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peristaltic dissolution apparatus: prediction of relative in vivo performance of prednisone tablets in humans.
    Simmons DL; Legore AA; Picotte P
    J Pharm Sci; 1980 Feb; 69(2):220-2. PubMed ID: 7359333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability: a new type of in vitro--in vivo correlation exemplified by prednisone.
    Sullivan TJ; Sakmar E; Wagner JG
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):173-81. PubMed ID: 950589
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative bioavailability of prednisone and prednisolone in man.
    Tse FL; Welling PG
    J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
    Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA
    J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA; Sibley CR; Buller RH
    J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednisone per os is likely to have limited efficacy in horses.
    Peroni DL; Stanley S; Kollias-Baker C; Robinson NE
    Equine Vet J; 2002 May; 34(3):283-7. PubMed ID: 12108748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two dissolution apparatuses with correlation of in vitro-in vivo data for prednisone and prednisolone tablets.
    Milsap RL; Ayres JW; Mackichan JJ; Wagner JG
    Biopharm Drug Dispos; 1979; 1(1):3-17. PubMed ID: 552859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM; Brandenberger AW; Frey FJ; Widmer HR
    Pharm Acta Helv; 1984; 59(11):301-9. PubMed ID: 6514760
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative bioavailability of two commercial preparations of carbamazepine tablets.
    Anttila M; Kahela P; Panelius M; Yrjänä T; Tikkanen R; Aaltonen R
    Eur J Clin Pharmacol; 1979 Jul; 15(6):421-5. PubMed ID: 583039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.